secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elevation Oncology, Inc. (—)
CIK:        0001783032
Form:       8-K
Filed at:   2025-01-31T23:59:59+00:00
Accession:  0001558370-25-000574
Event type: leadership
Sentiment:  negative
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Elevation Oncology CSO David Dornan resigns effective Feb 17, 2025; to assist as consultant
--------------------------------------------------------------------------------

- Chief Scientific Officer David Dornan, Ph.D., resigns effective February 17, 2025.
- Resignation is not based on any disagreement with the company on any matter.
- Dornan will continue to assist Elevation Oncology as a consultant to support transition.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1783032/000155837025000574/0001558370-25-000574-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1783032/000155837025000574/elev-20250129x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-25-000574

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer